03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Professor Sarah Flanagan
Professor of the University of Exeter Medical School
press citation on 1 topic since 6 May 2026 · last quoted 6 May 2026
02 Quoted on · 1 of 29 topics
Professor Sarah Flanagan: key facts
- Kind of voice
- Academic
- Role
- Professor of the University of Exeter Medical School
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 6 May 2026
04 The signal · where Professor Sarah Flanagan sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Maya MatthewsSector leaderHead of Unit for Health Technology Assessment at the European Commission1
- 25=Dr Jayne HoughtonAcademiclead Clinical Scientist for this project at the Royal Devon University Healthcare NHS Foundation Trust1
- 25=Professor Sarah FlanaganAcademicProfessor of the University of Exeter Medical School1
- 25=David MargolinAcademicM.D., Ph.D., VP of clinical development at uniQure1
- 25=Kelley KidwellAcademicPh.D., University of Michigan biostatistician1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Professor Sarah Flanagan has said
- news.exeter.ac.uk1
Where Professor Sarah Flanagan has been quoted
- 01Exeter leads rare disease global genetic testing project, improving access and saving young livesnews.exeter.ac.uk · 6 May 2026
Verbatim
“In Exeter, we are committed to ensuring that every child born with congenital hyperinsulinism, wherever they are in the world, can benefit from rapid, state-of-the-art genetic testing something that has not previously been possible. This project combines Exeter's world-leading genetics expertise with knowledge of the condition and funding from Congenital Hyperinsulinism International.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.